More critically, SMAD4 expression has been reported to be down‐regulated in the articular cartilage of osteoarthritis patients,83 and TGF‐β/SMAD4 pathway activation alleviated the progression of diabetes‐related osteoarthritis.84 Here, SMAD4 is linked to diabetes mellitus.